Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.

被引：0
|
作者：
Thiery-Vuillemin, Antoine
Tartas, Sophie
Mourey, Loic
Colomba, Emeline
Borchiellini, Delphine
Goujon, Morgan
Lefort, Felix
Topart, Delphine
Barthelemy, Philippe
Lauridant, Geraldine
Meurisse, Aurelia
Vernerey, Dewi
Massard, Vincent
机构：
[1] Ctr Hosp Reg Univ, Med Oncol, Besancon, France
[2] South Lyon Hosp Ctr, Lyon, France
[3] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[4] Gustave Roussy, Villejuif, France
[5] Ctr Antoine Lacassagne, Nice, France
[6] CHRU Besancon, Inst Reg Fed Canc, Oncol Med, Besancon, France
[7] Univ Bordeaux, CHU Bordeaux, Dept Med Oncol, Hop St Andre, Bordeaux, France
[8] CHU Montpellier, Montpellier, France
[9] Inst Cancerol Strasbourg Europe, Strasbourg, France
[10] Les Dentellieres, Valenciennes, France
[11] Univ Hosp, Dept Oncol, Methodol & Qual Life Unit, INSERM UMR 1098, Besancon, France
[12] UMQVC, Besancon, France
[13] Univ Hosp Besancon, Besancon, France
[14] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE
    Gassian, Noemie
    Frontczak, Alexandre
    Mouillet, Guillaume
    Vernerey, Dewi
    Manseur, Ouiza
    Goujon, Morgan
    Meurisse, Aurelia
    Berthod, Diane
    Robert, Elise
    Calcagno, Fabien
    Thiery-Vuillemin, Antoine
    BULLETIN DU CANCER, 2020, 107 (05) : ES16 - ES21
  • [2] PULSE: A single arm trial assessing the activity and safety of avelumab immunotherapy maintenance among patients with locally advanced or metastatic squamous cell penile carcinoma (mSCPC)
    Gassian, N.
    Mouillet, G.
    Vernerey, D.
    Manseur, O.
    Frontczak, A.
    Meurisse, A.
    Berthod, D.
    Robert, E.
    Calcagno, F.
    Thiery-Vuillemin, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 402 - 402
  • [3] Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy
    Sharma, Padmanee
    Sohn, Joohyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Gizzi, Marco
    Kalinka, Ewa
    de Vos, Filip Y. F. L.
    Ruscica, Dario
    Ferro, Salvatore
    Xiao, Feng
    Baverel, Paul
    Chen, Cecil Chi-Keung
    Asubonteng, Kobby
    Morsli, Nassim
    Dirix, Luc
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 61 - 70
  • [4] First-line Maintenance Therapy in adult Patients with locally advanced or metastatic Urothelial Carcinoma who are progression-free after platinum-based Chemotherapy
    Rexer, Heidrun
    Gschwend, Jurgen
    Merseburger, Axel S.
    AKTUELLE UROLOGIE, 2024, 55 (04) : 297 - 298
  • [5] Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen H.
    Gupta, Shilpa
    Hutson, Thomas E.
    Sternberg, Cora N.
    Brown, Jason
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie A.
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 697 - 697
  • [6] Trial in progress: A phase 2, randomized, open-label study of trilaciclib with first-line, platinum-based chemotherapy and avelumab maintenance in untreated patients with locally advanced or metastatic urothelial carcinoma (PRESERVE 3).
    Sonpavde, Guru P.
    Grivas, Petros
    Milowsky, Matthew I.
    Galsky, Matt D.
    Malik, Rajesh K.
    Beelen, Andrew Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [7] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [8] A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma
    Munhoz, Rodrigo R.
    Nader-Marta, Guilherme
    de Camargo, Veridiana P.
    Queiroz, Marcello M.
    Cury-Martins, Jade
    Ricci, Herminia
    de Mattos, Marcela R.
    de Menezes, Thiago A. F.
    Machado, Guilherme U. C.
    Bertolli, Eduardo
    Barros, Milton
    de Souza, Carina E.
    Franke, Fabio
    Ferreira, Fabio O.
    Feher, Olavo
    de Castro Jr, Gilberto
    CANCER, 2022, 128 (24) : 4223 - 4231
  • [9] MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).
    Gupta, Shilpa
    Ballman, Karla V.
    Galsky, Matt D.
    Morris, Michael J.
    Sridhar, Srikala S.
    Chen, Ronald C.
    Chan, Timothy An-Thy
    Wen, Yujia
    Grivas, Petros
    Tan, Alan
    Baghaie, Shiva
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
    Park, Se Hoon
    Shin, Sang Joon
    Rha, Sun Young
    Beom, Seung-Hoon
    Seo, Ho Kyung
    Keam, Bhumsuk
    Kim, Miso
    Hong, Yoon-Hee
    Yoon, Shinkyo
    Lee, Jae-Lyun
    FRONTIERS IN ONCOLOGY, 2024, 14
12345